Protagonist Therapeutics, Inc.: Protagonist Therapeutics Announces Pricing of $100 Million Public Offering of Shares of Common Stock
NEWARK, CA / ACCESSWIRE / April 4, 2023 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced the pricing of its previously announced underwritten public offering of
Source: finanznachrichten.de